VirA (952376)

  https://cordis.europa.eu/project/id/952376

  Horizon 2020 (2014-2020)

  Reducing networking gaps between Rīga Stradiņš University (RSU) and internationally - leading counterparts in viral infection-induced autoimmunity research

  Twinning (WIDESPREAD-05-2020)

  mortality  ·  virology  ·  autoimmune diseases  ·  personalized medicine

  2020-12-01 Start Date (YY-MM-DD)

  2023-11-30 End Date (YY-MM-DD)

  € 899,992 Total Cost

  Description

The specific challenge of VirA Twinning project is to enhance networking activities between the Riga Stradins University (RSU) located in Latvia as a Widening country and internationally-leading counterparts at EU level, in the field of autoimmunity research. RSU is an institution that has proven itself over several decades on a local and regional level as an important island of research excellence in viral infection-induced autoimmunity research. Further raising the research excellence requires widening the network and establishing closer cooperation with global leaders in science, sharpening the institutional profile of RSU. Project aims at strengthening the close scientific cooperation with counterparts: in Italy - University of Ferrara, in Germany - Ulm University, and in Israel - Tel-Aviv University. The partner universities are the excellence centres (world leaders) that are forerunners in immunology, virology, morphology and clinical data management and modelling, and are capable of inspiring positive change in the research field and significantly influence future developments at RSU via joint activities. Systemic autoimmune diseases (SAD) are a significant cause of morbidity and mortality worldwide, creating a challenge for researchers and clinicians to find evidence-based solutions for SAD diagnostics, treatment and prevention. Due to the complexity of autoimmune disease research, which requires multidisciplinary approaches, a problem is insufficient research capacity at low-performing EU Member State research institutions. Research capacity, able to deliver precise and early diagnostic is of high importance to move towards the development of methods for personalized medicine and better understanding of triggers and mechanisms in autoimmunity, leading to better understanding of chronic diseases and comorbidities and searching for therapy options. VirA project will optimally address the challenges and strengthen the ERA in autoimmunity.

  Complicit Organisations

1 Israeli organisation participates in VirA.